WHO Announces Influenza Vaccine Recommendations for the 2025-2026 Season
On March 1, 2025, the World Health Organization (WHO) unveiled its recommendations for the viral composition of influenza vaccines for the upcoming 2025–2026 influenza season in the northern hemisphere. This announcement came at the conclusion of a four-day meeting dedicated to the Composition of Influenza Virus Vaccines, an event held biannually to ensure that vaccines are effective against the ever-evolving influenza viruses.
The WHO organizes these critical consultations with a panel of experts sourced from WHO Collaborating Centres and WHO Essential Regulatory Laboratories. Together, they analyze extensive influenza virus surveillance data provided by the WHO Global Influenza Surveillance and Response System (GISRS). The insights gained during these meetings inform national vaccine regulatory agencies and pharmaceutical companies as they develop, produce, and license influenza vaccines for the forthcoming season.